Senior FDA official Vinay Prasad reportedly overrode his staff in deciding to reject Moderna's application for a new seasonal flu shot.
Moderna's Phase III trial will test out its experimental vaccine in 25,000 people over the next two years.
The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor cancers.
Stéphane Bancel said the pharma company's partnership with OpenAI will help transform its business
Professors Katalin Karikó and Drew Weissman published a paper in 2005 that showed the mRNA could be modified to create more effective vaccines.
This week, the FDA gave the go-ahead for Moderna and Pfizer to update their respective mRNA vaccines, which will be tuned to combat the latest variants.
The CDC's advisory committee recommended this month that adults over 60 can receive one of two RSV vaccines, setting the stage for wide distribution this year.
In a large Phase III trial, GlaxoSmithKline's Arexvy substantially reduced people's risk of severe complications from respiratory syncytial virus infection.
In people over 60, the mRNA-based vaccine appeared over 80% effective at preventing symptoms linked to lower respiratory infections caused by the virus.
In patients with advanced melanoma, the vaccine along with immunotherapy reduced the risk of cancer recurrence and death by 44%, the companies said.
Satanic ingredients, mass death, and other debunked talking points from the anti-vaccination movement.
In She's In Ctrl: How Women Can Take Back Tech, Dr. Anne- Marie Imafidon explores how the stories we tell ourselves about women can inspire our futures.
Experimental therapies are coming down the pipeline, while existing and recently approved drugs are providing people with more options for keeping their hair.
The new generation of boosters, which protect against the latest Omicron variants as well as the original coronavirus, will likely be available within weeks.
The Massachusetts-based company claims that Pfizer and BioNTech lifted two key pieces of its mRNA vaccine platform without proper compensation.
Digging into DARPA's history to suss out the agency's most significant, sometimes scary research from the last two decades.
Second covid-19 boosters for the general population are reportedly being postponed in favor of new and improved shots.
The FDA says children between 5 and 11 years old can now receive a third shot of the Pfizer vaccine.
Research suggests that vaccinated people who caught Omicron tend to develop more robust immunity to past and present strains of the coronavirus.
No other covid-19 vaccine is currently authorized for use in children younger than six years old.
